New Pharmaceutical Patent Reports from DrugPatentWatch.com

New pharmaceutical patent intelligence reports profile patent challenges, orphan drugs, and leading inventors
 
Jan. 20, 2012 - PRLog -- DrugPatentWatch has updated its pharmaceutical patent intelligence reports, profiling profile patent challenges, orphan drugs, and leading inventors.

The following reports have been updated for 2012 and are now available through the DrugPatentWatch.com report store at http://www.DrugPatentWatch.com/reports:

DRUG PATENT CHALLENGE REPORT
- The Drug Patent Challenge Report profiles the companies that successfully challenged pharmaceutical drug patents since 2000.

ORPHAN DRUG REPORT
- The Orphan Drug Report profiles pharmaceutical drugs with FDA Orphan Drug Exclusivity since 2000.

DRUG PATENT INVENTOR REPORTS
- The Drug Patent Inventor Reports profile the individuals who have been awarded pharmaceutical drug patents since 2000.

Individual country profiles are available for:
- Australia
- Belgium
- Canada
- China
- Denmark
- Finland
- France
- Germany
- Ireland
- India
- Israel
- Italy
- Japan
- Netherlands
- Norway
- South Korea
- Spain
- Sweden
- Switzerland
- United Kingdom
- United States

For complete details, see the DrugPatentWatch.com store at http://www.DrugPatentWatch.com/reports:

# # #

DrugPatentWatch provides comprehensive information on drug patents and their expirations.This value-added information supports patent agents and attorneys, pharmaceutical companies, wholesalers, healthcare payers, and investors.
End
Source:DrugPatentWatch.com
Email:***@drugpatentwatch.com Email Verified
Tags:Patent, Pharmaceutical, Challenge, Paragraph Iv, Drug
Industry:Medical, Biotech, Pharmaceutical
Location:D.C. - Washington - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
DrugPatentWatch News
Trending
Daily News
Weekly News



Like PRLog?
9K2K1K
Click to Share